We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-16.63%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.74B
AUM Growth
-$332M
Cap. Flow
+$1.39B
Cap. Flow %
15.88%
Top 10 Hldgs %
14.69%
Holding
702
New
131
Increased
128
Reduced
92
Closed
142

Top Buys

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$172M
2
TWLO icon
Twilio
TWLO
+$165M
3
ADBE icon
Adobe
ADBE
+$133M
4
RNG icon
RingCentral
RNG
+$113M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$107M

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$95.4M
2
MCK icon
McKesson
MCK
+$74.7M
3
SYK icon
Stryker
SYK
+$73.5M
4
MSFT icon
Microsoft
MSFT
+$70.2M
5
VMW
VMware, Inc
VMW
+$69.6M

Sector Composition

Rank Sector Weight
1 Technology 25.33%
2 Healthcare 15.6%
3 Industrials 12.5%
4 Financials 11.66%
5 Consumer Discretionary 10.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRZN icon
501
Surrozen
SRZN
$301M
$917K 0.01%
20,377
– –
SLDB icon
502
Solid Biosciences
SLDB
$900M
$904K 0.01%
97,950
+10,000
+11% +$104K
KDNY
503
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$875K 0.01%
+50,000
New +$785K
SCTL
504
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$849K 0.01%
1,068,386
-180,840
-14% -$194K
HOWL icon
505
Werewolf Therapeutics
HOWL
$19.3M
$843K 0.01%
206,201
– –
DLCA
506
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$836K 0.01%
85,000
– –
ATXS
507
DELISTED
Astria Therapeutics
ATXS
$824K 0.01%
274,719
– –
JOBY icon
508
Joby Aviation
JOBY
$8.55B
$822K 0.01%
167,434
-525,000
-76% -$2.77M
AERI
509
DELISTED
Aerie Pharmaceuticals
AERI
$750K 0.01%
100,000
– –
OTLY
510
Oatly Group
OTLY
$438M
$747K 0.01%
10,797
-27,684
-72% -$2.16M
PMGM
511
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$744K 0.01%
75,000
– –
TCDA
512
DELISTED
Tricida, Inc. Common Stock
TCDA
$726K 0.01%
75,000
– –
LIAN
513
DELISTED
LianBio American Depositary Shares
LIAN
$711K 0.01%
329,186
-10,056
-3% -$34.1K
RAIN
514
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$695K 0.01%
125,000
– –
PRDS
515
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$691K 0.01%
225,000
– –
VERV
516
DELISTED
Verve Therapeutics
VERV
$688K 0.01%
45,000
– –
CMI icon
517
Cummins
CMI
$88.7B
$677K 0.01%
3,497
+1,899
+119% +$380K
ZWRK
518
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
$669K 0.01%
68,001
– –
GRAB icon
519
Grab
GRAB
$14.9B
$633K 0.01%
250,000
+194,601
+351% +$559K
VLD
520
DELISTED
Velo3D, Inc.
VLD
$618K 0.01%
12,800
+2,857
+29% +$334K
SBUX icon
521
Starbucks
SBUX
$120B
$604K 0.01%
7,906
-272,559
-97% -$20.9M
PGY icon
522
Pagaya Technologies
PGY
$1.78B
$592K 0.01%
+11,801
New +$745K
SLS icon
523
SELLAS Life Sciences
SLS
$2.36B
$566K 0.01%
+254,018
New +$745K
XOS icon
524
Xos
XOS
$37.7M
$534K 0.01%
9,678
– –
MLGO
525
MicroAlgo
MLGO
$45.6M
$511K 0.01%
8
– –
19 20
21
22 23

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2022 Portfolio in Review

As of Q2 2022, Alyeska Investment Group held 702 positions worth $8.74B, down 3.7% from $9.07B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group deployed $1.39B of net new capital in Q2 2022, opening 131 new positions and adding to 128 existing holdings. Its largest new stake was Atlassian: 803,823 shares worth $151M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Costco, an estimated $95.4M trimmed.

  • Alyeska Investment Group's largest Q2 2022 buy was Atlassian: 803,823 shares worth $151M.
  • Alyeska Investment Group added most to Twilio in Q2 2022, an estimated $165M increase.
  • Alyeska Investment Group's biggest Q2 2022 reduction was Costco, cutting an estimated $95.4M.
  • Alyeska Investment Group fully exited McKesson in Q2 2022, selling an estimated $74.7M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $8.74B portfolio in Q2 2022.
  • Alyeska Investment Group opened 131 new positions and closed 142 in Q2 2022.
  • Alyeska Investment Group's portfolio value fell 3.7% quarter-over-quarter to $8.74B.

Based on Alyeska Investment Group's 13F filing for Q2 2022, filed 15 Aug 2022.